Wegovy may help with heart issues: Analysis
(NewsNation) — Patients who took the weight-loss drug Wegovy showed significantly reduced heart risk in addition to maintaining weight loss, according to the results from Novo Nordisk's longest clinical trial.
In addition to weight loss, the 17,604-patient trial, called Select, tested Wegovy's heart-protective benefits for overweight and obese patients who had pre-existing heart disease but not diabetes.
Results showed that patients lost an average of nearly 10% of their total body weight after 65 weeks on Wegovy.
Заголовки